Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Forum
  • About Us
    • Our Coverage
    • Team

ISR Immune System Regulation

Less than 1K followers
All
Webcasts
Press releases
ShowingAll content types
Regulatory press release8/28/2023, 10:01 AM

ISR's, SARS-CoV-2 dry powder nasal - vaccine booster candidate, ISR52, demonstrates superior immune response, in mouse model challenge studies compared to subcutaneous injection of this vaccine.

ISR Immune System Regulation
ISR, Audiocast with teleconference, Half-year report 2022
Webcast9/1/2022, 8:30 AM

ISR, Audiocast with teleconference, Half-year report 2022

ISR Immune System Regulation
Regulatory press release7/1/2022, 8:20 AM

ISR: SARS-CoV-2 vaccine study approved by Bangladesh BMRC

ISR Immune System Regulation

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Regulatory press release6/28/2022, 1:00 PM

ISR signs development agreements with Catalent to scale-up its spray-dried nasal vaccine, powder formulation for Phase III.

ISR Immune System Regulation
Regulatory press release6/28/2022, 1:00 PM

ISR signs development agreements with Catalent to scale-up its spray-dried nasal vaccine, powder formulation for Phase III.

ISR Immune System Regulation
Regulatory press release6/20/2022, 1:45 PM

Delegation from Bangladesh visits ISR for study preparation

ISR Immune System Regulation
Press release5/5/2022, 5:35 AM

Redeye: Redeye Initiates Coverage of ISR Holding

ISR Immune System Regulation
ISR, Audiocast with teleconference, Year-end Report, 2021
Webcast2/23/2022, 12:00 PM

ISR, Audiocast with teleconference, Year-end Report, 2021

ISR Immune System Regulation
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Forum
  • About Us
    • Our Coverage
    • Team